Literature DB >> 8989684

Pharmacology of coronary vasodilation: a brief review.

C Orlandi1.   

Abstract

Successful scintigraphic imaging of coronary artery stenosis is dependent on detecting regional differences (nonhomogeneous distribution) in coronary blood flow that can be induced by physiologic or pharmacologic stress. Table 1 represents a summary of major pharmacologic responses of the heart to the four agents discussed above. Both adenosine and dipyridamole produce superior coronary vasodilation and tend to be preferred for use in single-photon emission computed tomography, whereas dobutamine and arbutamine provoke a marked ischemic response and tend to be preferred for use in echocardiography. Which agent employed remains a judgment of the physician based on known side effects of these agents, the patient's ability to tolerate these side effects, and the nature of the test desired.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8989684     DOI: 10.1016/s1071-3581(96)90205-6

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  24 in total

1.  Effects of adenosine on human coronary arterial circulation.

Authors:  R F Wilson; K Wyche; B V Christensen; S Zimmer; D D Laxson
Journal:  Circulation       Date:  1990-11       Impact factor: 29.690

Review 2.  Myocardial perfusion imaging during pharmacologic stress testing.

Authors:  J J Mahmarian; M S Verani
Journal:  Cardiol Clin       Date:  1994-05       Impact factor: 2.213

Review 3.  The role of adenosine in the regulation of coronary blood flow.

Authors:  R M Berne
Journal:  Circ Res       Date:  1980-12       Impact factor: 17.367

4.  Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry.

Authors:  M D Cerqueira; M S Verani; M Schwaiger; J Heo; A S Iskandrian
Journal:  J Am Coll Cardiol       Date:  1994-02       Impact factor: 24.094

5.  Arbutamine stress thallium-201 single-photon emission computed tomography using a computerized closed-loop delivery system. Multicenter trial for evaluation of safety and diagnostic accuracy. The International Arbutamine Study Group.

Authors:  H Kiat; A S Iskandrian; B J Villegas; M R Starling; D S Berman
Journal:  J Am Coll Cardiol       Date:  1995-11-01       Impact factor: 24.094

6.  Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise.

Authors:  M S Verani; J J Mahmarian; J B Hixson; T M Boyce; R A Staudacher
Journal:  Circulation       Date:  1990-07       Impact factor: 29.690

Review 7.  Pharmacological cardiac stress: when and how?

Authors:  D J Pennell
Journal:  Nucl Med Commun       Date:  1994-08       Impact factor: 1.690

8.  Intravenous dipyridamole combined with isometric handgrip for near maximal acute increase in coronary flow in patients with coronary artery disease.

Authors:  B G Brown; M A Josephson; R B Petersen; C D Pierce; M Wong; H S Hecht; E Bolson; H T Dodge
Journal:  Am J Cardiol       Date:  1981-12       Impact factor: 2.778

9.  Symptoms, adverse effects, and complications associated with dobutamine stress echocardiography. Experience in 1118 patients.

Authors:  H Mertes; S G Sawada; T Ryan; D S Segar; R Kovacs; J Foltz; H Feigenbaum
Journal:  Circulation       Date:  1993-07       Impact factor: 29.690

10.  Acute effect of systemic versus intracoronary dipyridamole on coronary circulation.

Authors:  E Marchant; A Pichard; J A Rodriguez; P Casanegra
Journal:  Am J Cardiol       Date:  1986-06-01       Impact factor: 2.778

View more
  5 in total

Review 1.  Selective adenosine agonists and myocardial perfusion imaging.

Authors:  Gilbert J Zoghbi; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-02       Impact factor: 5.952

2.  Preconditioning protects against ischemia/reperfusion injury of the liver.

Authors:  B Nilsson; S Friman; B I Gustafsson; D S Delbro
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

3.  Prevalence and significance of electrocardiographic changes and side effect profile of regadenoson compared with adenosine during myocardial perfusion imaging.

Authors:  Maliha Zahid; Aaysha Kapila; Cecelia E Eagan; David A Yusko; Edwin D Miller; Cheryl D Missenda
Journal:  J Cardiovasc Dis Res       Date:  2013-02-27

Review 4.  Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge.

Authors:  Yasmeen Golzar; Rami Doukky
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-01-22

5.  Comparative Performances of Dipyridamole and Regadenoson to Detect Myocardial Ischemia using Cardiac Cadmium-Zinc-Telluride Single-Photon Emission Computerized Tomography.

Authors:  Fayçal Ben Bouallçgue; Catherine Nganoa; Jonathan Vigne; Denis Agostini; Alain Manrique
Journal:  J Clin Imaging Sci       Date:  2018-11-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.